Search Results - "Barro, Christian"
-
1
Serum neurofilament light levels in normal aging and their association with morphologic brain changes
Published in Nature communications (10-02-2020)“…Neurofilament light (NfL) protein is a marker of neuro-axonal damage and can be measured not only in cerebrospinal fluid but also in serum, which allows for…”
Get full text
Journal Article -
2
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
Published in Neurology (05-03-2019)“…OBJECTIVETo assess the value of blood neurofilament light chain (NfL) as a biomarker of recent, ongoing, and future disease activity and tissue damage and its…”
Get full text
Journal Article -
3
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Published in Brain (London, England : 1878) (01-08-2018)“…See Giovannoni (doi:10.1093/brain/awy200) for a scientific commentary on this article. Biomarkers of tissue damage in multiple sclerosis are urgently needed…”
Get full text
Journal Article -
4
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
Published in Clinical chemistry and laboratory medicine (01-10-2016)“…Neuronal damage is the morphological substrate of persisting neurological disability. Neurofilaments (Nf) are specific cytoskeletal proteins of neurons and…”
Get more information
Journal Article -
5
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
Published in Annals of neurology (01-06-2017)“…Objective Neurofilament light chains (NfL) are unique to neuronal cells, are shed to the cerebrospinal fluid (CSF), and are detectable at low concentrations in…”
Get full text
Journal Article -
6
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
Published in Neurology (24-09-2019)“…OBJECTIVETo test the hypothesis that serum levels of glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL), which are an intermediate…”
Get full text
Journal Article -
7
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Published in Multiple sclerosis (01-04-2019)“…Background: Monitoring neuronal injury remains one key challenge in early relapsing-remitting multiple sclerosis (RRMS) patients. Upon axonal damage,…”
Get full text
Journal Article -
8
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis
Published in Neurology (02-01-2018)“…OBJECTIVETo examine neurofilament (Nf) concentrations according to symptom onset and clinical diagnostic certainty categories of amyotrophic lateral sclerosis…”
Get full text
Journal Article -
9
Fluid biomarker and electrophysiological outcome measures for progressive MS trials
Published in Multiple sclerosis (01-10-2017)“…Progressive multiple sclerosis (MS) is characterized by insidious clinical worsening that is difficult to accurately quantify and predict. Biofluid markers and…”
Get full text
Journal Article -
10
Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
Published in Journal of the peripheral nervous system (01-06-2019)“…Axonal damage in chronic inflammatory demyelinating polyneuropathy (CIDP) is the main predictor of poor outcome. We hypothesized that serum neurofilament light…”
Get full text
Journal Article -
11
Fingolimod in children with Rett syndrome: the FINGORETT study
Published in Orphanet journal of rare diseases (06-01-2021)“…Rett syndrome (RS) is a severe neurodevelopmental disorder for which there is no approved therapy. This study aimed to assess safety and efficacy of oral…”
Get full text
Journal Article -
12
Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
Published in Annals of clinical and translational neurology (01-09-2019)“…Background Gray matter (GM) pathology is closely associated with physical and cognitive impairment in persons with multiple sclerosis (PwMS). Similarly, serum…”
Get full text
Journal Article -
13
Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
Published in Journal of stroke (01-05-2018)“…Neurofilament light chain (NfL) is a blood marker for neuroaxonal damage. We assessed the association between serum NfL and cerebral small vessel disease…”
Get full text
Journal Article -
14
Validation of Two Kinetic Assays for the Quantification of Endotoxin in Human Serum
Published in Frontiers in neurology (25-06-2021)“…Background: There is an emerging evidence of the role of the microbiome in neurological diseases. Endotoxin is a component of gram-negative bacteria and…”
Get full text
Journal Article -
15
Blood neurofilament light as a potential endpoint in Phase 2 studies in MS
Published in Annals of clinical and translational neurology (01-06-2019)“…Objectives To assess whether neurofilament light chain (NfL) could serve as an informative endpoint in Phase 2 studies in patients with relapsing–remitting…”
Get full text
Journal Article -
16
Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease
Published in Journal of stroke (01-09-2020)“…Background and Purpose Serum neurofilament light (NfL)-chain is a circulating marker for neuroaxonal injury and is also associated with severity of cerebral…”
Get full text
Journal Article -
17
Impact of parturition on maternal cardiovascular and neuronal integrity in a high risk cohort - a prospective cohort study
Published in BMC pregnancy and childbirth (05-11-2019)“…To better understand the profound multisystem changes in maternal physiology triggered by parturition, in particular in the underexplored neuronal system, by…”
Get full text
Journal Article -
18
Neurofilament Light Chain: Blood Biomarker of Neonatal Neuronal Injury
Published in Frontiers in neurology (20-11-2018)“…Neurofilament light chain (NfL) is a highly promising biomarker of neuroaxonal injury that has mainly been studied in adult neurodegenerative disease. Its…”
Get full text
Journal Article -
19
Reader Response: Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials
Published in Neurology (04-10-2022)Get full text
Journal Article -
20
Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003)
Published in Brain and behavior (01-02-2021)“…Background High‐dose pharmaceutical‐grade biotin (MD1003) has positive effects on disability in progressive multiple sclerosis (PMS), but its mechanism of…”
Get full text
Journal Article